Inbrija 42 mg/1 (Levodopa CAPSULE) 42 mg/1

Inbrija 42 mg/1 is an inhaled levodopa capsule designed for respiratory administration. It is commonly used for the treatment of Parkinson's disease symptoms, offering a convenient alternative to oral medications. This product is manufactured by Merz Pharmaceuticals, LLC in the USA.

Strength

42 mg/1

Pack Size

1 BLISTER PACK in 1 CARTON (10144-342-04) / 4 CAPSULE in 1 BLISTER PACK (10144-342-01)

Manufacturer / TM Owner

Merz Pharmaceuticals, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Inbrija 42 mg/1 is primarily used for the management of Parkinson's disease symptoms. It is designed to provide quick relief from motor fluctuations, such as 'off' periods, which are common in Parkinson's patients. The inhaled form allows for rapid absorption, making it a useful option for those who experience delayed or inconsistent relief from oral levodopa.

Side Effects

Common effects of Inbrija 42 mg/1 may include improved mobility and reduced stiffness. Some users may experience temporary improvements in motor function shortly after administration. As with any medication, individual responses can vary, and it is important to monitor for any adverse reactions.

Precautions & Warnings

Inbrija 42 mg/1 should be used with caution, especially in individuals with a history of respiratory conditions. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always store the medication in a cool, dry place and keep it out of reach of children.

Avoid Interactions

Inbrija 42 mg/1 may interact with other medications, including those that affect dopamine levels or respiratory function. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness of Inbrija.

Frequently Asked Questions

Inbrija 42 mg/1 is used to manage symptoms of Parkinson's disease, particularly motor fluctuations.

Inbrija 42 mg/1 is administered via inhalation using a specialized device provided with the medication.

Common effects include improved mobility and reduced stiffness, though individual responses may vary.

It is important to consult a healthcare provider before combining Inbrija 42 mg/1 with other medications to avoid potential interactions.

Inbrija 42 mg/1 can be purchased from authorized online pharmacies and e-commerce platforms.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.